News

Pharmabiz26m
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Thursday, July ...
Pharmabiz12m
KSPC launches maiden virtual simulation-based pharma manufacturing training programme
KSPC launches maiden virtual simulation-based pharma manufacturing training programme: Our Bureau, Bengaluru Thursday, July 3, 2025, 17:15 Hrs [IST] Karnataka State Pharmacy Counc ...
Pharmabiz56m
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks: Our Bureau, New Delhi Thursday, July 3, 2025, 16:30 Hrs [IST] After the Central government, the indust ...
Pharmabiz1h
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...
Pharmabiz2h
Hemispherian’s GLIX1 to treat malignant glioma receives US FDA orphan drug designation
Hemispherian’s GLIX1 to treat malignant glioma receives US FDA orphan drug designation: Oslo, Norway Thursday, July 3, 2025, 15:00 Hrs [IST] Hemispherian AS, an Oslo-based pharm ...
Pharmabiz3h
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...
Pharmabiz4h
Sobi to amend existing agreement with Apellis for ex-US royalties of Aspaveli
Sobi to amend existing agreement with Apellis for ex-US royalties of Aspaveli: Stockholm, Sweden Thursday, July 3, 2025, 13:00 Hrs [IST] Sobi, a global biopharma company, announce ...
Pharmabiz5h
IDMA Telangana meets DG of Telangana DCA to address key issues facing pharma industry in the state
IDMA Telangana meets DG of Telangana DCA to address key issues facing pharma industry in the state: Our Bureau, Mumbai Thursday, July 3, 2025, 12:10 Hrs [IST] The Telangana State ...
Pharmabiz5h
Novocure to present final secondary endpoint data from phase 3 PANOVA-3 trial at ESMO Congress 2025
Baar, Switzerland Thursday, July 3, 2025, 12:00 Hrs [IST] ...
Pharmabiz6h
HanchorBio signs licensing agreement with Shanghai Henlius Biotech to develop and commercialise rights to HCB101 across Greater China
HanchorBio signs licensing agreement with Shanghai Henlius Biotech to develop and commercialise rights to HCB101 across Greater China: Taipei, Shanghai Thursday, July 3, 2025, 11: ...
Pharmabiz7h
BioVersys & Shionogi ink global research collaboration for broad-spectrum NTM clinical candidate
BioVersys & Shionogi ink global research collaboration for broad-spectrum NTM clinical candidate: Basel, Switzerland Thursday, July 3, 2025, 10:00 Hrs [IST] BioVersys AG, a multi- ...
Pharmabiz6h
Tamil Nadu state pharmacy council elects new members
The 9th Tamil Nadu state pharmacy council election concluded on Wednesday morning, July 2nd, with the returning officer announcing the results in the afternoon. Six candidates who secured the highest ...